Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis
Clinical trial NCT04620213 · COMPLETED
Trial details
- NCT number
- NCT04620213
- Sponsor
- Ocuphire Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2020-12-23
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.